Patterson definitely has some conflicts of interes
Post# of 148179
For example, Patterson recently filed a patent on the use of RANTES as a diagnostic indicator for leronlimab in covid19.
If Patterson's patent proves dispositive, the patent could dictate the leronlimab dosing schedule in covid19.
No doubt Cytodyn prefers not to have Patterson's patent regulating dosing schedules in covid19.